Skip to Main Content

Paper Details

Safety and Efficacy of Warfarin Therapy in Kawasaki Disease.
J Pediatr
12
2017
CAA, CAA thrombosis, CAAs, Kawasaki Disease, Kawasaki disease, Warfarin, aspirin, children, coronary thrombosis, giant coronary artery aneurysms, patient, patients, warfarin
Author NameAffiliation
Annette L BakerBoston Children's Hospital
Kimberlee GauvreauBoston Children's Hospital, Harvard Medical School
David R FultonBoston Children's Hospital, Harvard Medical School
Sarah D de FerrantiBoston Children's Hospital, Harvard Medical School
Kevin G FriedmanBoston Children's Hospital, Harvard Medical School
Christopher S AlmondBoston Children's Hospital, Harvard Medical School
Jane W NewburgerBoston Children's Hospital, Harvard Medical School
Jane W NewburgerBoston Children's Hospital, Harvard Medical School
  • 1 - 8

Datasets

Release 1.2